BOTWOOD NICHOLAS A.J. (Head of R&D, CMO) purchased 50.3% of their position (11.77K shares) of SYNDAX PHARMACEUTICALS INC on the open market
Open‑market purchase worth $105.8K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 5/19/2025ACC: 0000950170-25-074301
Officer· Head of R&D, CMO
Since Feb 2026
+11.77K
Net shares
Net buyer
$105.8K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
11.77K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+11.77K
Price / share
$8.99
Trade value
$105.83K
% of position
50.3%
5/16/2025
23.40K→35.16K
Total
Net shares
+11.77K
Net value
$105.83K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/16/2025 | P · Purchase | +11.77K | $8.99 | $105.83K | 50.3% | 23.40K | 35.16K |
| Total | +11.77K | $105.83K | ||||||
Derivative Transactions0
No derivative transactions reported